Ferdinand Anton Weinelt (Ferdinand A Weinelt, Ferdinand Weinelt)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Systematic Review

Circulating Tumor Cells

Patients Undergoing

Top Venues

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Carius, Ferdinand Anton Weinelt, Chris Cantow, Markus Holstein, Aaron M Teitelbaum, Yunhai Cui
Addressing the ADME Challenges of Compound Loss in a PDMS-Based Gut-on-Chip Microphysiological System. Pharmaceutics 16 (3) (2024)
Patrick Carius, Ferdinand Anton Weinelt, Chris Cantow, Markus Holstein, Aaron M Teitelbaum, Yunhai Cui
Addressing the ADME Challenges of Compound Loss in a PDMS-Based Gut-on-Chip Microphysiological System. Pharmaceutics 16 (3) (2024)
Patrick Carius, Ferdinand Anton Weinelt, Chris Cantow, Markus Holstein, Aaron M Teitelbaum, Yunhai Cui
Addressing the ADME Challenges of Compound Loss in a PDMS-Based Gut-on-Chip Microphysiological System. Pharmaceutics 16 (3) (2024)
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, Otto Frey, Sebastian Greppmair, Ferdinand Anton Weinelt, Michael Zoller, Christina Scharf, Georg Hempel, Uwe Liebchen
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 67 (5) (2023)
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, Otto Frey, Sebastian Greppmair, Ferdinand Anton Weinelt, Michael Zoller, Christina Scharf, Georg Hempel, Uwe Liebchen
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 67 (5) (2023)
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, Otto Frey, Sebastian Greppmair, Ferdinand Anton Weinelt, Michael Zoller, Christina Scharf, Georg Hempel, Uwe Liebchen
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy (2023)
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, Otto Frey, Sebastian Greppmair, Ferdinand Anton Weinelt, Michael Zoller, Christina Scharf, Georg Hempel, Uwe Liebchen
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 67 (5) (2023)
Lea Marie Schatz, Alexander Brinkmann, Anka Röhr, Otto Frey, Sebastian Greppmair, Ferdinand Anton Weinelt, Michael Zoller, Christina Scharf, Georg Hempel, Uwe Liebchen
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 67 (5) (2023)
Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, Frieder Pfäfflin, Stephan Achterberg, Franz Weber, Lucas Dübel, Agata Mikolajewska, Alexander Uhrig, Peggy Kiessling, Wilhelm Huisinga, Robin Michelet, Stefanie Hennig, Charlotte Kloft
Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, Frieder Pfäfflin, Stephan Achterberg, Lisa Schmitt, Wilhelm Huisinga, Robin Michelet, Stefanie Hennig, Charlotte Kloft
Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing-A Translational Example for Intensive Care Units. Pharmaceutics 13 (12) (2021)
Uwe Liebchen, Marian Klose, Michael Paal, Michael Vogeser, Michael Zoller, Ines Schroeder, Lisa Schmitt, Wilhelm Huisinga, Robin Michelet, Johannes Zander, Christina Scharf, Ferdinand Anton Weinelt, Charlotte Kloft
Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients. Antibiotics (Basel, Switzerland) 10 (4) (2021)